KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Receivables - Net: 2015-2025

Historic Receivables - Net for Medpace Holdings (MEDP) over the last 9 years, with Sep 2025 value amounting to $373.0 million.

  • Medpace Holdings' Receivables - Net rose 19.77% to $373.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $373.0 million, marking a year-over-year increase of 19.77%. This contributed to the annual value of $296.4 million for FY2024, which is 0.66% down from last year.
  • As of Q3 2025, Medpace Holdings' Receivables - Net stood at $373.0 million, which was down 1.29% from $377.9 million recorded in Q2 2025.
  • Medpace Holdings' 5-year Receivables - Net high stood at $377.9 million for Q2 2025, and its period low was $160.0 million during Q1 2021.
  • Its 3-year average for Receivables - Net is $305.6 million, with a median of $298.2 million in 2025.
  • In the last 5 years, Medpace Holdings' Receivables - Net soared by 40.48% in 2022 and then fell by 0.66% in 2024.
  • Quarterly analysis of 5 years shows Medpace Holdings' Receivables - Net stood at $186.4 million in 2021, then soared by 35.92% to $253.4 million in 2022, then rose by 17.76% to $298.4 million in 2023, then dropped by 0.66% to $296.4 million in 2024, then grew by 19.77% to $373.0 million in 2025.
  • Its Receivables - Net stands at $373.0 million for Q3 2025, versus $377.9 million for Q2 2025 and $298.2 million for Q1 2025.